By Rich Haridy September 28, 2022 Over 18 months those on lecanemab showed a 27% slower rate of cognitive decline compared to those in the placebo group Depositphotos Pharmaceutical companies Eisai and Biogen have announced the first results from a Phase 3 human trial testing a drug designed to treat symptoms of dementia associated with...
Increasingly prevalent worldwide, dementia negatively affects the lives of millions of people and their families. By the time of diagnosis, the process appears to be irreversible. The new research in JAMA Network Open, however, identifies muscle mass as a modifiable factor that could potentially be used to decrease the risk of developing the condition, before it’s...
by Public Library of Science Moderate drinking is associated with brain iron accumulation. Credit: Mischa Hafferty (CC-BY 4.0, creativecommons.org/licenses/by/4.0/) Consumption of seven or more units of alcohol per week is associated with higher iron levels in the brain, according to a study of almost 21,000 people publishing July 14 in the open access journal PLOS Medicine. Iron accumulation...
by Bob Yirka, Medical Xpress Graphical abstract. Credit: Cell Host & Microbe (2022). DOI: 10.1016/j.chom.2022.05.005 A team of researchers from the Brown Cancer Center, the University of Louisville, Peak Neuromonitoring Associates, the University of Texas and the University of Louisville has found that a metabolite produced by bacteria in the gut promotes neural cell death resulting in...
by eLife This image shows the effects of aging effects on the brain, further exacerbated in type 2 diabetes. Credit: Lilianne Mujica-Parodi (CC BY 4.0) Scientists have demonstrated that normal brain aging is accelerated by approximately 26% in people with progressive type 2 diabetes compared to individuals without the disease, reports a study published today...
by University College London Credit: CC0 Public Domain The researchers set out to see if there had been an increase in the numbers of older people who were reporting their first concerns about memory loss or cognitive decline to their doctor and what their chances of developing dementia were after consultation. The study, published today...
by UT Southwestern Medical Center Credit: Pixabay/CC0 Public Domain Cognitive decline is the biggest factor in determining how long patients with Alzheimer’s disease will live after being diagnosed, according to a new study from researchers at UT Southwestern. The findings, published in the Journal of Alzheimer’s Disease, are a first step that could help health care providers...
by Yale University PET scan of a human brain with Alzheimer’s disease. Credit: public domain Advanced imaging technology developed by Yale researchers has helped them confirm that the destruction of brain synapses underlies the cognitive deficits experienced by patients with Alzheimer’s disease, according to a study published Feb. 17 in the journal Alzheimer’s & Dementia. For...
By Rich Haridy February 01, 2022 New research homes in on a mechanism that could explain how brain iron levels increase with age Researchers at Northwestern Medicine have uncovered a mechanism they say contributes to the age-related accumulation of iron in the brain, a process some argue is a cause of cognitive decline. The study...
by King’s College London Credit: Public Domain New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London suggests that a virtual reality test in which participants “go to the shops” could offer a potentially promising way of effectively assessing functional cognition, the thinking and processing skills needed to accomplish complex...
